Dianthus Therapeutics (DNTH) PT Raised to $63 at Raymond James
Tweet Send to a Friend
Raymond James analyst Steven Seedhouse raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $63.00 (from $56.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
